Overview A Study of RDEA806 in Hyperuricemic Subjects With Symptomatic Gout Status: Completed Trial end date: 2009-09-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether RDEA806 is effective in the treatment of hyperuricemia in gout patients. Phase: Phase 2 Details Lead Sponsor: Ardea Biosciences, Inc.